O'Shaughnessy Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

O'Shaughnessy Asset Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-646	Closed	-$65K	–	2667
2021 Q3	$65K	Buy	646 +636	+6,360%	+$74.5K	﹤0.01%	1547
2021 Q2	$1K	Hold	10	–	–	﹤0.01%	2529
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	2322
2020 Q4	$1K	Sell	10 -1,004	-99%	-$132K	﹤0.01%	2028
2020 Q3	$99K	Sell	1,014 -89	-8%	-$11.1K	﹤0.01%	905
2020 Q2	$172K	Sell	1,103 -285	-21%	-$43.3K	0.01%	690
2020 Q1	$201K	Sell	1,388 -7	-0.5%	-$1.35K	0.01%	468
2019 Q4	$285K	Buy	+1,395	New	+$254K	0.01%	527

Other funds holding RETA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

O'Shaughnessy Asset Management's RETA Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q4 2021, closing a stake of 646 shares — an estimated $65K sold.

O'Shaughnessy Asset Management first reported a position in RETA in Q4 2019 and held it in 8 quarters. The position peaked at $285K in Q4 2019. 151 funds tracked by Wall St. Rank hold RETA as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 646 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q4 2021, an estimated $65K.
O'Shaughnessy Asset Management first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2019 and held it in 8 quarters.
O'Shaughnessy Asset Management's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $285K in Q4 2019.
151 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.